Status:
UNKNOWN
Robot-assisted Gait Training in Patients With Multiple Sclerosis: Efficacy and Comparison With Traditional Methods
Lead Sponsor:
Habilita, Ospedale di Sarnico
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
In Multiple Sclerosis (MS) gait disorders represent one of the most disabling aspect that strongly influence patient quality of life. The improvement of walking ability is a primary goal for rehabilit...
Detailed Description
In Multiple Sclerosis (MS), the highly variable distribution of demyelinization areas and axonal loss in the Central Nervous System can lead to very complex and unpredictable neurological deficits and...
Eligibility Criteria
Inclusion
- diagnosis of multiple sclerosis according to the McDonald's Criteria in stable phase of disease for at least 3 months.
- ability to walk 25 foot without assistance
- EDSS score between 3.5 and 7
Exclusion
- exacerbations of the disease in the last 3 months
- deficits of somatic sensation involving the legs
- other neurological, orthopedic or cardiovascular co-morbility
- severe posture abnormalities
- severe-moderate cognitive impairment (Mini Mental State ≤ 21)
- body weight greater than 135 kg;
- height more than 200 cm;
- limb-length discrepancy greater than 2 cm;
- presence of skin lesions on the trunk, pelvis and lower limbs that could interfere with the placement of the electrodes and straps anchoring the Lokomat.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2016
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT02291107
Start Date
June 1 2014
End Date
June 1 2016
Last Update
August 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HABILITA
Zingonia Di Ciserano, Bergamo, Italy, 24040